Popular search terms:
Search Results Label
17 results found-
Seqirus | A World Leader in Influenza Vaccines
Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.
https://www.seqirus.ca/ -
SEQIRUS CANADA INC.
These terms and conditions (hereinafter "Terms") govern the purchase for the 2018-2019 Influenza Season of the seasonal influenza vaccines from Seqirus Canada Inc. ("Seqirus").
https://www.seqirus.ca/-/media/seqirus-canada/docs-en/seqirus-canada-inc-terms-and-conditions-final-doc-eng.pdf -
Seqirus announces Health Canada approval of first cell-based
Seqirus announces Health Canada approval of first cell-based seasonal influenza vaccine
https://www.seqirus.ca/...l-based-seasonal-influenza-vaccine -
Seqirus | About Us
Seqirus is a global influenza vaccine company developing innovative solutions to ensure epidemic and pandemic preparedness throughout the world.
https://www.seqirus.ca/our-company -
Fluad Ped-Fluad ASU Product Monograph
(FLUAD Pediatric ® : 1800; conventional non-adjuvanted trivalent and investigational quadrivalent influenza comparator vaccines: 2083; other non-influenza control vaccines: 208).
https://www.seqirus.ca/-/media/seqirus-canada/docs-en/fluad-product-monograph-17june2019.pdf -
John Minardo
Our leadership team is composed of experienced professionals with deep scientific expertise and a shared commitment to public health. Meet them now.
https://www.seqirus.ca/our-company/leadership/john-minardo -
FLUAD MASTER LIST OF REFERENCES
Accessed 30 April 2019 24. 2018-2019 Publicly funded seasonal influenza vaccines. Available at: https://www.immunize.ca/sites/default/files/Resource%20and%20Product%20Uploads%20(PD
https://www.seqirus.ca/-/media/seqirus-canada/docs-en/fluad-master-list-of-references-31jul19.pdf -
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION FLUCELVAX
There are no reproductive and developmental toxicology studies with FLUCELVAX ® QUAD. Reproductive and developmental toxicology data from trivalent influenza vaccines do not
https://www.seqirus.ca/-/media/seqirus-canada/docs-en/flucelvax-quad-pm-22-nov-2019.pdf -
Sitemap
Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.
https://www.seqirus.ca/sitemap -
COVID19 Update
Read the latest news from Seqirus, a world leader in developing and producing influenza vaccines.
https://www.seqirus.ca/news/covid19-update